Heart Disease News and Research

Latest Heart Disease News and Research

Rethinking fundamental rule of stroke care: 'Time is brain!'

In 1993, neurologist Camilo R. Gomez, MD, coined a phrase that for a quarter century has been a fundamental rule of stroke care: "Time is brain!"

14 Aug 2018

OncoThira and NDSU enter into license agreement to develop, market cancer compounds

The NDSU Research Foundation and OncoThira have entered into a license agreement involving technology developed at North Dakota State University.

14 Aug 2018

Google's DeepMind AI could soon be diagnosing eye conditions

London-based DeepMind which is owned by Google’s parent company Alphabet, is coming up with Artificial Intelligence based devices that can help diagnose eye conditions accurately.

14 Aug 2018

AI platform identifies acute neurological illnesses faster than human diagnosis

An artificial intelligence platform designed to identify a broad range of acute neurological illnesses, such as stroke, hemorrhage, and hydrocephalus, was shown to identify disease in CT scans in 1.2 seconds, faster than human diagnosis, according to a study conducted at the Icahn School of Medicine at Mount Sinai and published today in the journal Nature Medicine.

14 Aug 2018

Simple score helps predict which hospitalized heart attack patients are at high risk of readmissions

Tracking just seven factors of heart attack patients when they are first admitted to the hospital can help flag those most at risk for 30-day readmission, researchers from UT Southwestern found.

13 Aug 2018

New genome analysis could identify people at higher risk of common deadly diseases

A research team at the Broad Institute of MIT and Harvard, Massachusetts General Hospital (MGH), and Harvard Medical School reports a new kind of genome analysis that could identify large fractions of the population who have a much higher risk of developing serious common diseases, including coronary artery disease, breast cancer, or type 2 diabetes.

13 Aug 2018

New test predicts the risk of serious disease months before symptoms appear

Researchers have developed a new genetic test that can identify people who are at an increased risk of serious disease, long before they develop any symptoms.

13 Aug 2018

Researchers find link between common 'harmless' virus and cardiovascular damage

Researchers from Brighton and Sussex Medical School have found an unexpectedly close link between a herpes virus and the occurrence of immune cells damaging cardiovascular tissue.

13 Aug 2018

Lighter sedation fails to reduce risk of postoperative delirium in older patients

Johns Hopkins Medicine researchers say a study designed to see if reducing the amount of anesthesia reduces the risk of postoperative delirium in older patients surprisingly found that lighter sedation failed to do so in severely ill people undergoing hip fracture repair.

13 Aug 2018

Grip strength of children predicts future cardiometabolic health

While other studies have shown that muscle weakness as measured by grip strength is a predictor of unhealthy outcomes -- including cardiovascular and metabolic diseases, disability and even early mortality -- this is the first to do so for adolescent health over time, a Baylor University researcher said.

13 Aug 2018

Researchers discover epigenetic mechanism underlying ischemic cardiomyopathy

Researchers at the University of Alabama at Birmingham have shed light on an epigenetic reprogramming mechanism that underlies the development of ischemic cardiomyopathy.

13 Aug 2018

Advances in treating hep C lead to new option for transplant patients

After her kidneys failed from the same illness that took the lives of her mother and brother, Anne Rupp went on dialysis in May 2016, spending three hours a day, three times a week undergoing the blood-cleaning procedure. She hated it.

13 Aug 2018

Oxidative Stress Hampers Blood Vessel Dilation in Men

Higher levels of oxidative stress in males results in lower levels of cofactor BH needed to make the powerful blood vessel dilator nitric oxide.

13 Aug 2018

Incidence of coronary artery compression in children may be more common than previously thought

The incidence of coronary artery compression in children fitted with epicardial pacemakers may be slightly more common than previously believed, say noted cardiologists.

13 Aug 2018

New biomarker may provide clues to create diagnostic tool for hypoglycemia-associated autonomic failure

A new LSU Pennington Biomedical Research Center study reveals that a novel biomarker might give us new answers necessary to creating a diagnostic tool for hypoglycemia-associated autonomic failure.

13 Aug 2018

NIH awards $6.5 million to establish multi-institution biomedical technology resource center

The National Institutes of Health have awarded $6.5 million to a consortium that includes the Icahn Institute for Genomics and Multiscale Biology at the Icahn School of Medicine at Mount Sinai, the University of Washington, the University of Connecticut, and the University of Auckland, New Zealand, to establish the Center for Reproducible Biomedical Modeling.

13 Aug 2018

FDA approves first oral medication for treatment of adults with Fabry disease

The U.S. Food and Drug Administration today approved Galafold (migalastat), the first oral medication for the treatment of adults with Fabry disease.

10 Aug 2018

FDA approves first vaginal ring contraceptive that can be used for one year

The U.S. Food and Drug Administration today approved Annovera (segesterone acetate and ethinyl estradiol vaginal system), which is a combined hormonal contraceptive for women of reproductive age used to prevent pregnancy and is the first vaginal ring contraceptive that can be used for an entire year.

10 Aug 2018

Average consumption of salt found to be safe for heart health

New research shows that for the vast majority of individuals, sodium consumption does not increase health risks except for those who eat more than five grams a day, the equivalent of 2.5 teaspoons of salt.

10 Aug 2018

FDA approves first targeted RNA-based treatment for rare, fatal genetic disease

The U.S. Food and Drug Administration today approved Onpattro (patisiran) infusion for the treatment of peripheral nerve disease (polyneuropathy) caused by hereditary transthyretin-mediated amyloidosis (hATTR) in adult patients.

10 Aug 2018